NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nanjing Superyears Gene Technology Co., Ltd.

Nanjing Superyears Gene Technology Co., Ltd.

Private
NanjingHealthcare & Life Scienceshttps://superyears.com/

Last Round

Series A

Sep 24, 2023

Total Funding Raised

$8.24M

Company Overview

Nanjing Superyears Gene Technology Co., Ltd. is a biotechnology company that develops and manufactures high-end scientific instruments, including genetic analyzers and real-time PCR systems.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

genetic analyzerSanger sequencercapillary electrophoresisreal-time PCRqPCRforensic DNA analysisDNA sequencinglab instrumentationmolecular biology equipmentglycan analyzerclinical diagnosticsfragment analysisbiotech reagentslab consumablesgenomics hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanjing Superyears Gene Technology Co., Ltd. Comparables

Compare Nanjing Superyears Gene Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Nanjing Superyears Gene Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ningbo HEALTH Gene Technologies Co., Ltd.
91%
Thermo Fisher Scientific Inc.
78%
AGCU ScienTech Incorporation
78%

Nanjing Superyears Gene Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 24, 2023

Key People

Founding team and executive leadership

Xiaofang Zhao

CEO

Executive Team

Nanjing Superyears Gene Technology Co., Ltd. Investors

Notable investors and investment history

Nanjing Superyears Gene Technology Co., Ltd. investors
InvestorRounds
Anhui Guokong Capital Co., Ltd.Series A

Nanjing Superyears Gene Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanjing Superyears Gene Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanjing Superyears Gene Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range22
Year Founded2017
Last FundingSep 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.